Seattle, Washington — According to state and local development sources, Curi Bio plans to build out 13,942 square feet of new space in Seattle. The company plans to occupy the new space at 201 Elliott Ave. W in Seattle, on or about March 1, 2025. According to the company website Human Data for Next Generation Medicines Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency

To learn more about Curi Bio, visit http://www.curibio.com/

Company Contact:
Nicholas Geisse, Chief Executive Officer
https://www.linkedin.com/in/nicholas-geisse/
800-913-4403

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.